Published in Healthcare Mergers, Acquisitions and Ventures Week, October 30th, 2010
As a result of this limited distribution agreement, BioRx will also be added as a distributor of ARALAST NP, a similar product to Baxter's first alpha-1 proteinase inhibitor (A1-Pi), ARALAST, originally launched in 2003....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.